EUVIMEDEUVIMED entdecken
Open Access · CC0

Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome

Christopher E Morgan, Yoon-Suk Kang, Alex B Green, Kenneth P Smith, Matthew G Dowgiallo, Brandon C Miller, Lucius Chiaraviglio, Katherine A Truelson, Katelyn E Zulauf, Shade Rodriguez, Anthony D Kang, Roman Manetsch und 2 weitere

PLOS Biology · 16.05.2023 · 21 (5) · e3002091

DOI: 10.1371/journal.pbio.3002091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 16.05.2023. Verfasst von Christopher E Morgan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Streptothricins. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The streptothricin natural product mixture (also known as nourseothricin) was discovered in the early 1940s, generating intense initial interest because of excellent gram-negative activity. Here, we establish the activity spectrum of nourseothricin and its main components, streptothricin F (S-F, 1 lysine) and streptothricin D (S-D, 3 lysines), purified to homogeneity, against highly drug-resistant, carbapenem-resistant Enterobacterales (CRE) and Acinetobacter baumannii . For CRE, the MIC 50 and MIC 90 for S-F and S-D were 2 and 4 μM, and 0.25 and 0.5 μM, respectively. S-F and nourseothricin showed rapid, bactericidal activity. S-F and S-D both showed approximately 40-fold greater selectivity for prokaryotic than eukaryotic ribosomes in in vitro translation assays. In vivo, delayed renal toxicity occurred at >10-fold higher doses of S-F compared with S-D. Substantial treatment effect of S-F in the murine thigh model was observed against the otherwise pandrug-resistant, NDM-1-expressing Klebsiella pneumoniae Nevada strain with minimal or no toxicity. Cryo-EM characterization of S-F bound to the A . baumannii 70S ribosome defines extensive hydrogen bonding of the S-F steptolidine moiety, as a guanine mimetic, to the 16S rRNA C1054 nucleobase ( Escherichia coli numbering) in helix 34, and the carbamoylated gulosamine moiety of S-F with A1196, explaining the high-level resistance conferred by corresponding mutations at the residues identified in single rrn operon E . coli . Structural analysis suggests that S-F probes the A-decoding site, which potentially may account for its miscoding activity. Based on unique and promising activity, we suggest that the streptothricin scaffold deserves further preclinical exploration as a potential therapeutic for drug-resistant, gram-negative pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStreptothricinsAnimalsMiceEscherichia coliRNA, Ribosomal, 16SGram-Negative BacteriaCarbapenemsRibosomesMicrobial Sensitivity Tests

Substanzen

Anti-Bacterial Agentsstreptothricin FStreptothricinsRNA, Ribosomal, 16SCarbapenems

Autor:innen und Institutionen

  • Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America.
  • Harvard Medical School, Boston, Massachusetts, United States of America.
  • Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts, United States of America.
  • Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America.
  • Center for Drug Discovery, Northeastern University, Boston, Massachusetts, United States of America.

ORCID-Profile: James E Kirby

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Morgan, C. E., Kang, Y. S., Green, A. B., Smith, K. P., Dowgiallo, M. G., Miller, B. C., Chiaraviglio, L., Truelson, K. A., Zulauf, K. E., Rodriguez, S., Kang, A. D., Manetsch, R., Yu, E. W., & Kirby, J. E. (2023). Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome. PLOS Biology, 21(5), e3002091. https://doi.org/10.1371/journal.pbio.3002091

Vancouver

Morgan CE, Kang YS, Green AB, Smith KP, Dowgiallo MG, Miller BC, et al. Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome. PLOS Biology. 2023;21(5):e3002091. doi:10.1371/journal.pbio.3002091

BibTeX
@article{Morgan2023,
  author = {Morgan, Christopher E and Kang, Yoon-Suk and Green, Alex B and Smith, Kenneth P and Dowgiallo, Matthew G and Miller, Brandon C and Chiaraviglio, Lucius and Truelson, Katherine A and Zulauf, Katelyn E and Rodriguez, Shade and Kang, Anthony D and Manetsch, Roman and Yu, Edward W and Kirby, James E},
  title = {Streptothricin F is a bactericidal antibiotic effective against highly drug-resistant gram-negative bacteria that interacts with the 30S subunit of the 70S ribosome},
  journal = {PLOS Biology},
  year = {2023},
  volume = {21},
  number = {5},
  pages = {e3002091},
  doi = {10.1371/journal.pbio.3002091}
}
Kostenlos starten →